Top compounds associated with response to CLEC19A


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.0042 0.9
mRNA RO4929097 CTRPv2 pan-cancer AAC -0.0065 0.9
mRNA PI-103 CTRPv2 pan-cancer AAC -0.0042 0.9
mRNA CCT036477 CTRPv2 pan-cancer AAC -0.004 0.9
mRNA cediranib CTRPv2 pan-cancer AAC -0.0065 0.9
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.0043 0.9
mRNA YL54 CTRPv2 pan-cancer AAC -0.0046 0.9
mRNA AT7867 CTRPv2 pan-cancer AAC -0.0041 0.9
mRNA TAE684 CTRPv2 pan-cancer AAC 0.004 0.9
mRNA PL-DI CTRPv2 pan-cancer AAC -0.0035 0.9
Download CSV